• Clinical Technology
  • Adult Immunization
  • Hepatology
  • Pediatric Immunization
  • Screening
  • Psychiatry
  • Allergy
  • Women's Health
  • Cardiology
  • Pediatrics
  • Dermatology
  • Endocrinology
  • Pain Management
  • Gastroenterology
  • Infectious Disease
  • Obesity Medicine
  • Rheumatology
  • Nephrology
  • Neurology
  • Pulmonology

12 Drugs Approved for Primary Care in 2021

News
Slideshow

With 2021 nearing an end, Patient Care Online has compiled a list of key drugs approved this year by the US Food and Drug Administration for conditions that are often seen in primary care. Scroll through the slides below to find details on the novel COVID-19 vaccine, a novel agent for the treatment of heart failure, the first and only antihistamine nasal spray for allergies available over-the-counter, and 9 more.

Related Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Related Content
First Blood Test for Alzheimer Disease Diagnosis Cleared by FDA for Primary Care Use: Daily Dose / Image credit: ©New Africa/AdobeStock

First Blood Test for Alzheimer Disease Diagnosis Cleared by FDA for Primary Care Use: Daily Dose

Sydney Jennings
December 2nd 2025
Article

Your daily dose of the clinical news you may have missed.

Weekly Dose Podcast: New Insights on Colonoscopy Adherence, rt-CGM in GDM, Semaglutide Effects, Parent Vaccine Views, and MI Causes

Weekly Dose Podcast: New Insights on Colonoscopy Adherence, rt-CGM in GDM, Semaglutide Effects, Parent Vaccine Views, and MI Causes

Sydney Jennings
November 13th 2025
Podcast

Topics include rideshare support for colonoscopy, rt-CGM benefits in GDM, semaglutide and food noise, vaccine views, and MI etiology.

Obesity Linked to Faster Alzheimer’s Disease Progression in Longitudinal Blood Biomarker Analysis / image credit Cyrus Raji, MD, PhD Courtesy of RSNA

Obesity Linked to Faster Alzheimer Disease Progression in Longitudinal Blood Biomarker Analysis

Grace Halsey
December 2nd 2025
Article

Biomarker trajectories over 5 years in study participants with AD show steeper rises in pTau217, NfL, and amyloid burden among those with obesity, highlighting risk factor relevance.

Weekly Dose Podcast: Depression Risk After Chronic Illness, Vaginal Estradiol Safety, GLP-1 Updates, Cancer Risk Reduction, and Cardiovascular Outcomes

Weekly Dose Podcast: Depression Risk After Chronic Illness, Vaginal Estradiol Safety, GLP-1 Updates, Cancer Risk Reduction, and Cardiovascular Outcomes

Sydney Jennings
September 24th 2025
Podcast

Today's episode covers depression risk after chronic illness, vaginal estradiol safety, GLP-1 updates, cancer risk, and cardiovascular outcomes.

Merck Secures Fast Track for Novel AD Antibody and Reports First-in-Human Data / image credit ©Yankovych/stock.adobe.com

Merck Secures Fast Track for Novel AD Antibody and Reports First-in-Human Data

Grace Halsey
December 1st 2025
Article

New safety and biomarker results from MK-2214 and MK-1167 advance Merck’s dual approach to Alzheimer therapy.

Evolocumab Associated with Lower Long-term Cardiovascular Event Risk in Real-world Study of More Than 110 000 Patients

Evolocumab Associated with Lower Long-term Cardiovascular Event Risk in Real-world Study of More Than 110 000 Patients

Sydney Jennings
December 1st 2025
Article

New data reveals evolocumab significantly reduces long-term major cardiovascular event risks in ASCVD patients, enhancing treatment strategies for better outcomes.

© 2025 MJH Life Sciences

All rights reserved.